CAPR(Capricor Therapeutics, Inc.) · 财务报表

CAPR(Capricor Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$244.90K$2.55M$25.18M$22.27M$0
毛利润—————
营业利润−$20.94M−$29.70M−$24.08M−$42.56M−$108.14M
净利润−$20.02M−$29.02M−$22.29M−$40.47M−$105.04M
经营现金流−$16.81M$4.92M−$25.60M−$40.00M−$69.81M
自由现金流−$18.01M$2.92M−$26.91M−$41.16M−$72.72M
摊薄每股收益$-0.87$-1.18$-0.83$-1.15$-2.26

Capricor Therapeutics, Inc. CAPR